A carregar...
Crystal structure of rofecoxib bound to human cyclooxygenase-2
Rofecoxib (Vioxx) was one of the first selective cyclooxygenase-2 (COX-2) inhibitors (coxibs) to be approved for use in humans. Within five years after its release to the public, Vioxx was withdrawn from the market owing to the adverse cardiovascular effects of the drug. Despite the widespread knowl...
Na minha lista:
| Publicado no: | Acta Crystallogr F Struct Biol Commun |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International Union of Crystallography
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5053162/ https://ncbi.nlm.nih.gov/pubmed/27710942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1107/S2053230X16014230 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|